Delivery Order SPE2DB22D2009-SPE2DB25FM1BB
- Not listed
- The Defense Logistics Agency awarded a $8,078.82 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe format (0.5ML) with a firm fixed price and an ultimate completion date of July 11, 2025. This is a competitive, non-set-aside award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The award represents a child delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,735.59 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of PREVNAR 20 syringe vaccines (0.5mL) valued at $30,403.64. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a delivery order valued at $19,605.24 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $35,155.89 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PREVNAR 20 syringe units (0.5ML). This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open market solicitation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,406.74 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price delivery order was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order represents a task order...
- The Defense Logistics Agency awarded a $92,004.02 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringes under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This competitively awarded delivery order carries no set-aside designation and falls under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a $86,365.07 delivery order to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5mL) under a firm fixed-price contract type. The award, announced on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this medical supply delivery order, which will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $16,337.70 of PREVNAR 20 vaccine in 0.5mL syringes. Awarded on May 8, 2025, with completion expected by May 9, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under the agency's medical supply chain operations. No set-aside designation was applied to this award, indicating it was...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1BBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,747.18 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes. This competitive award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's consistent success in winning competitive awards across multiple therapeutic domains demonstrates its capability to meet federal medical supply requirements under the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 8/21/25 |